Join
Live feed
·
PRReleasevia Quantisnow
Reliance Global Group Inc. logo

Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA's Biotech Division

ByQuantisnow·Wall Street's wire, on your screen.
EZRA· Reliance Global Group Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EZRA (Reliance Global Group Inc.) and more on Quantisnow.